OpenEvidence’s $15 Billion Rise Shows How AI Search Is Monetizing Medicine
OpenEvidence, the fast-growing medical AI startup, is drawing intense investor attention as it scales toward a reported $15 billion valuation while doctors increasingly use its tools in clinical settings. The company’s rise underscores both the commercial promise of AI-powered medical search and the unresolved concerns around accuracy, transparency, and the role of advertising in healthcare decision-making.
